{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:28:56Z","timestamp":1790166536224,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Region of Southern Denmark","award":["18\/50638\/73"],"award-info":[{"award-number":["18\/50638\/73"]}]},{"name":"\u00d8stifterne Foundation","award":["19-063"],"award-info":[{"award-number":["19-063"]}]},{"DOI":"10.13039\/501100010343","name":"A. J. Andersen og hustrus Fond","doi-asserted-by":"publisher","award":["01737-0005\/JEB"],"award-info":[{"award-number":["01737-0005\/JEB"]}],"id":[{"id":"10.13039\/501100010343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10096-020-03861-4","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T05:03:49Z","timestamp":1594184629000},"page":"1461-1470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-7819","authenticated-orcid":false,"given":"Fredrikke Christie","family":"Knudtzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Christine","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joppe W.","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurdur","family":"Skarphedinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,14]]},"reference":[{"issue":"1","key":"3861_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I, European Federation of Neurological S (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(1):8\u201316, e11-14. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02862.x","journal-title":"Eur J Neurol"},{"issue":"9814","key":"3861_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/s0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser GP, Gray J, Strle F (2012) Lyme borreliosis. Lancet 379(9814):461\u2013473. https:\/\/doi.org\/10.1016\/s0140-6736(11)60103-7","journal-title":"Lancet"},{"issue":"4","key":"3861_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s11908-011-0184-x","volume":"13","author":"JJ Halperin","year":"2011","unstructured":"Halperin JJ (2011) Neurologic manifestations of Lyme disease. Curr Infect Dis Rep 13(4):360\u2013366. https:\/\/doi.org\/10.1007\/s11908-011-0184-x","journal-title":"Curr Infect Dis Rep"},{"issue":"4","key":"3861_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00415-011-6221-8","volume":"259","author":"M Djukic","year":"2012","unstructured":"Djukic M, Schmidt-Samoa C, Lange P, Spreer A, Neubieser K, Eiffert H, Nau R, Schmidt H (2012) Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis. J Neurol 259(4):630\u2013636. https:\/\/doi.org\/10.1007\/s00415-011-6221-8","journal-title":"J Neurol"},{"key":"3861_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/1471-2334-12-344","volume":"12","author":"JP Borde","year":"2012","unstructured":"Borde JP, Meier S, Fingerle V, Klier C, Hubner J, Kern WV (2012) CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings. BMC Infect Dis 12:344. https:\/\/doi.org\/10.1186\/1471-2334-12-344","journal-title":"BMC Infect Dis"},{"issue":"10","key":"3861_CR6","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1212\/01.wnl.0000269672.17807.e0","volume":"69","author":"F Blanc","year":"2007","unstructured":"Blanc F, Jaulhac B, Fleury M, de Seze J, de Martino SJ, Remy V, Blaison G, Hansmann Y, Christmann D, Tranchant C (2007) Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 69(10):953\u2013958. https:\/\/doi.org\/10.1212\/01.wnl.0000269672.17807.e0","journal-title":"Neurology"},{"issue":"8","key":"3861_CR7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1468-1331.2007.01799.x","volume":"14","author":"U Ljostad","year":"2007","unstructured":"Ljostad U, Skarpaas T, Mygland A (2007) Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 14(8):873\u2013876. https:\/\/doi.org\/10.1111\/j.1468-1331.2007.01799.x","journal-title":"Eur J Neurol"},{"issue":"12","key":"3861_CR8","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cmi.2018.04.007","volume":"24","author":"TA Rupprecht","year":"2018","unstructured":"Rupprecht TA, Manz KM, Fingerle V, Lechner C, Klein M, Pfirrmann M, Koedel U (2018) Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis. Clin Microbiol Infect 24(12):1234\u20131240. https:\/\/doi.org\/10.1016\/j.cmi.2018.04.007","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"3861_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00415-017-8669-7","volume":"265","author":"JN Wagner","year":"2018","unstructured":"Wagner JN, Weis S, Kubasta C, Panholzer J, von Oertzen TJ (2018) CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients. J Neurol 265(1):74\u201381. https:\/\/doi.org\/10.1007\/s00415-017-8669-7","journal-title":"J Neurol"},{"issue":"2","key":"3861_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jinf.2010.11.005","volume":"62","author":"I Tjernberg","year":"2011","unstructured":"Tjernberg I, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J (2011) Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. J Infect 62(2):149\u2013158. https:\/\/doi.org\/10.1016\/j.jinf.2010.11.005","journal-title":"J Infect"},{"key":"3861_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1742-2094-11-103","volume":"11","author":"J Hytonen","year":"2014","unstructured":"Hytonen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J (2014) CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. J Neuroinflammation 11:103. https:\/\/doi.org\/10.1186\/1742-2094-11-103","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3861_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12974-017-0789-6","volume":"14","author":"P Gyllemark","year":"2017","unstructured":"Gyllemark P, Forsberg P, Ernerudh J, Henningsson AJ (2017) Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study. J Neuroinflammation 14(1):27. https:\/\/doi.org\/10.1186\/s12974-017-0789-6","journal-title":"J Neuroinflammation"},{"issue":"10","key":"3861_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/jir.2016.0101","volume":"37","author":"J Yang","year":"2017","unstructured":"Yang J, Han X, Liu A, Bao F, Peng Y, Tao L, Ma M, Bai R, Dai X (2017) Chemokine CXC ligand 13 in cerebrospinal fluid can be used as an early diagnostic biomarker for Lyme neuroborreliosis: a meta-analysis. J Interf Cytokine Res 37(10):433\u2013439. https:\/\/doi.org\/10.1089\/jir.2016.0101","journal-title":"J Interf Cytokine Res"},{"issue":"12","key":"3861_CR14","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1097\/inf.0000000000001669","volume":"36","author":"B Barstad","year":"2017","unstructured":"Barstad B, Tveitnes D, Noraas S, Selvik Ask I, Saeed M, Bosse F, Vigemyr G, Huber I, Oymar K (2017) Cerebrospinal fluid B-lymphocyte chemoattractant CXCL13 in the diagnosis of acute Lyme neuroborreliosis in children. Pediatr Infect Dis J 36(12):e286\u2013e292. https:\/\/doi.org\/10.1097\/inf.0000000000001669","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"3861_CR15","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s10096-018-3334-3","volume":"37","author":"AJ Henningsson","year":"2018","unstructured":"Henningsson AJ, Lager M, Brannstrom R, Tjernberg I, Skogman BH (2018) The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis 37(10):1983\u20131991. https:\/\/doi.org\/10.1007\/s10096-018-3334-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"3861_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00115-014-4020-z","volume":"85","author":"TA Rupprecht","year":"2014","unstructured":"Rupprecht TA, Lechner C, Tumani H, Fingerle V (2014) CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine. Nervenarzt 85(4):459\u2013464. https:\/\/doi.org\/10.1007\/s00115-014-4020-z","journal-title":"Nervenarzt"},{"key":"3861_CR17","unstructured":"Denmark S StatBank Denmark: population at the first day of the quarter by region and time. https:\/\/statistikbanken.dk\/statbank5a\/default.asp?w=1440. Accessed 27-05-2019"},{"key":"3861_CR18","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HC, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351:h5527. https:\/\/doi.org\/10.1136\/bmj.h5527","journal-title":"BMJ"},{"issue":"5","key":"3861_CR19","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.ttbdis.2018.04.008","volume":"9","author":"M Markowicz","year":"2018","unstructured":"Markowicz M, Schotta AM, Kundi M, Bogovic P, Ogrinc K, Strle F, Stanek G (2018) CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA. Ticks Tick Borne Dis 9(5):1137\u20131142. https:\/\/doi.org\/10.1016\/j.ttbdis.2018.04.008","journal-title":"Ticks Tick Borne Dis"},{"issue":"1","key":"3861_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12974-017-0948-9","volume":"14","author":"MM Remy","year":"2017","unstructured":"Remy MM, Schobi N, Kottanattu L, Pfister S, Duppenthaler A, Suter-Riniker F (2017) Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study. J Neuroinflammation 14(1):173. https:\/\/doi.org\/10.1186\/s12974-017-0948-9","journal-title":"J Neuroinflammation"},{"key":"3861_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jns.2016.05.059","volume":"368","author":"D Picha","year":"2016","unstructured":"Picha D, Moravcova L, Smiskova D (2016) Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections. J Neurol Sci 368:214\u2013220. https:\/\/doi.org\/10.1016\/j.jns.2016.05.059","journal-title":"J Neurol Sci"},{"issue":"12","key":"3861_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/WNL.0b013e318211c39a","volume":"76","author":"C Schmidt","year":"2011","unstructured":"Schmidt C, Plate A, Angele B, Pfister HW, Wick M, Koedel U, Rupprecht TA (2011) A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 76(12):1051\u20131058. https:\/\/doi.org\/10.1212\/WNL.0b013e318211c39a","journal-title":"Neurology"},{"issue":"11","key":"3861_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/apm.12596","volume":"124","author":"AJ Henningsson","year":"2016","unstructured":"Henningsson AJ, Gyllemark P, Lager M, Skogman BH, Tjernberg I (2016) Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis. APMIS 124(11):985\u2013990. https:\/\/doi.org\/10.1111\/apm.12596","journal-title":"APMIS"},{"issue":"5","key":"3861_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s00415-008-0785-y","volume":"255","author":"U Ljostad","year":"2008","unstructured":"Ljostad U, Mygland A (2008) CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 255(5):732\u2013737. https:\/\/doi.org\/10.1007\/s00415-008-0785-y","journal-title":"J Neurol"},{"issue":"1","key":"3861_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12974-016-0745-x","volume":"13","author":"A Pietikainen","year":"2016","unstructured":"Pietikainen A, Maksimow M, Kauko T, Hurme S, Salmi M, Hytonen J (2016) Cerebrospinal fluid cytokines in Lyme neuroborreliosis. J Neuroinflammation 13(1):273. https:\/\/doi.org\/10.1186\/s12974-016-0745-x","journal-title":"J Neuroinflammation"},{"key":"3861_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2377-13-2","volume":"13","author":"D Bremell","year":"2013","unstructured":"Bremell D, Mattsson N, Edsbagge M, Blennow K, Andreasson U, Wikkelso C, Zetterberg H, Hagberg L (2013) Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol 13:2. https:\/\/doi.org\/10.1186\/1471-2377-13-2","journal-title":"BMC Neurol"},{"issue":"2","key":"3861_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ttbdis.2017.12.008","volume":"9","author":"M Karrasch","year":"2018","unstructured":"Karrasch M, Fingerle V, Boden K, Darr A, Baier M, Straube E, Nenadic I (2018) Neuroborreliosis and acute encephalopathy: the use of CXCL13 as a biomarker in CNS manifestations of Lyme borreliosis. Ticks Tick Borne Dis 9(2):415\u2013417. https:\/\/doi.org\/10.1016\/j.ttbdis.2017.12.008","journal-title":"Ticks Tick Borne Dis"},{"issue":"5","key":"3861_CR28","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1128\/jcm.00084-11","volume":"49","author":"ND van Burgel","year":"2011","unstructured":"van Burgel ND, Bakels F, Kroes AC, van Dam AP (2011) Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid. J Clin Microbiol 49(5):2027\u20132030. https:\/\/doi.org\/10.1128\/jcm.00084-11","journal-title":"J Clin Microbiol"},{"key":"3861_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12987-015-0008-8","volume":"12","author":"R Dersch","year":"2015","unstructured":"Dersch R, Hottenrott T, Senel M, Lehmensiek V, Tumani H, Rauer S, Stich O (2015) The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis. Fluids Barriers CNS 12:12. https:\/\/doi.org\/10.1186\/s12987-015-0008-8","journal-title":"Fluids Barriers CNS"},{"issue":"23","key":"3861_CR30","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1182\/blood-2013-01-476333","volume":"121","author":"JL Rubenstein","year":"2013","unstructured":"Rubenstein JL, Wong VS, Kadoch C, Gao HX, Barajas R, Chen L, Josephson SA, Scott B, Douglas V, Maiti M, Kaplan LD, Treseler PA, Cha S, Hwang JH, Cinque P, Cyster JG, Lowell C (2013) CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood 121(23):4740\u20134748. https:\/\/doi.org\/10.1182\/blood-2013-01-476333","journal-title":"Blood"},{"issue":"5","key":"3861_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/OLQ.0b013e3181d877a1","volume":"37","author":"CM Marra","year":"2010","unstructured":"Marra CM, Tantalo LC, Sahi SK, Maxwell CL, Lukehart SA (2010) CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis. Sex Transm Dis 37(5):283\u2013287. https:\/\/doi.org\/10.1097\/OLQ.0b013e3181d877a1","journal-title":"Sex Transm Dis"},{"issue":"5","key":"3861_CR32","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/infdis\/jix233","volume":"216","author":"Q Yu","year":"2017","unstructured":"Yu Q, Cheng Y, Wang Y, Wang C, Lu H, Guan Z, Huang J, Gong W, Shi M, Ni L, Wu J, Peng R, Zhou P (2017) Aberrant humoral immune responses in neurosyphilis: CXCL13\/CXCR5 play a pivotal role for B-cell recruitment to the cerebrospinal fluid. J Infect Dis 216(5):534\u2013544. https:\/\/doi.org\/10.1093\/infdis\/jix233","journal-title":"J Infect Dis"},{"key":"3861_CR33","doi-asserted-by":"publisher","first-page":"33569","DOI":"10.1038\/srep33569","volume":"6","author":"C Wang","year":"2016","unstructured":"Wang C, Wu K, Yu Q, Zhang S, Gao Z, Liu Y, Ni L, Cheng Y, Guan Z, Shi M, Lu H, Lou Y, Zhou P (2016) CXCL13, CXCL10 and CXCL8 as potential biomarkers for the diagnosis of neurosyphilis patients. Sci Rep 6:33569. https:\/\/doi.org\/10.1038\/srep33569","journal-title":"Sci Rep"},{"issue":"1","key":"3861_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/nib-150101","volume":"6","author":"AK Huber","year":"2015","unstructured":"Huber AK, Irani DN (2015) Targeting CXCL13 during neuroinflammation. Adv Neuroimmune Biol 6(1):1\u20138. https:\/\/doi.org\/10.3233\/nib-150101","journal-title":"Adv Neuroimmune Biol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03861-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-020-03861-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03861-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T19:25:44Z","timestamp":1615663544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-020-03861-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,14]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["3861"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-03861-4","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,14]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ICMJE forms for all authors are attached.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Danish Data Protection Agency (j.nr.19\/4365) and as a quality development project at Odense University Hospital (j.nr.18\/6688). The Danish National Committee on Health Research Ethics stated that no approval was required therefrom (j.nr.2019-2000-12).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"As this was a retrospective study, no individual patient consent was required. This was stated at approval by the Danish Data Protection Agency (j.nr.19\/4365) and Odense University Hospital (j.nr.18\/6688).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}